ABSTRACT
The COVID-19 outbreak, caused by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), was first identified in China, and it has quickly become a global threat to public health due to its rapid rate of transmission and fatalities. Angiotensin-converting enzyme 2 (ACE2) has been identified as a receptor that mediates the entry of SARS-CoV-2 into human cells, as in the case of severe acute respiratory syndrome coronavirus (SARS-CoV). Several studies have reported that ACE2 expression is higher in Leydig, Sertoli and seminiferous ductal cells of males, as well as in ovarian follicle cells of females, suggesting possible potential pathogenicity of the coronavirus in the reproductive system. Higher ACE2 expression in the human placenta and reports of vertical transmission of SARS-CoV-2 among clinical cases have increased the relevance of further studies in this area. This review focuses on the interaction between SARS-CoV-2 and the ACE2 receptor and speculates on the mechanistic interplay in association with male and female reproductive physiology. In addition, based on the available literature, we discuss the alleged sex differences in terms of the infectivity of SARS-CoV-2, which is claimed greater among males, and further explore the physiological role of ACE2 and 17ß-oestradiol for the same.
Subject(s)
Angiotensin-Converting Enzyme 2/metabolism , COVID-19/virology , Genitalia, Female/virology , Genitalia, Male/virology , Receptors, Virus/metabolism , Reproduction , SARS-CoV-2/pathogenicity , Virus Internalization , COVID-19/enzymology , COVID-19/epidemiology , COVID-19/physiopathology , Estradiol/metabolism , Female , Fertility , Genitalia, Female/enzymology , Genitalia, Female/physiopathology , Genitalia, Male/enzymology , Genitalia, Male/physiopathology , Host-Pathogen Interactions , Humans , Male , Risk Factors , SARS-CoV-2/metabolism , Sex Factors , Signal TransductionABSTRACT
Evidence shows coronavirus disease 2019 (COVID-19)-induced symptom severity and mortality is more frequent in men than in women, suggesting sex steroids may play a protective role. Female reproductive steroids, estrogen and progesterone, and its metabolite allopregnanolone, are anti-inflammatory, reshape competence of immune cells, stimulate antibody production, and promote proliferation and repair of respiratory epithelial cells, suggesting they may protect against COVID-19 symptoms.
Subject(s)
COVID-19/immunology , Estradiol/immunology , Estrogens/immunology , Immune System/immunology , Inflammation/immunology , Pregnanolone/immunology , Pregnenolone/immunology , Progesterone/immunology , Signal Transduction/immunology , Age Factors , Animals , COVID-19/metabolism , Estradiol/metabolism , Estrogens/metabolism , Female , Humans , Immune System/metabolism , Inflammation/metabolism , Male , Pregnanolone/metabolism , Pregnenolone/metabolism , Progesterone/metabolism , Sex FactorsABSTRACT
Epidemiological data in COVID-19 mortality indicate that men are more prone to die of SARS-CoV-2 infection than women, but biological causes for this sexual dimorphism are unknown. We discuss the prospective behavioral and biological differences between the sexes that could be attributed to this sex-based differentiation. The female sex hormones and the immune stimulatory genes, including Toll-like receptors, interleukins, and micro-RNAs present on X-chromosome, may impart lesser infectivity and mortality of the SARS-CoV-2 in females over males. The sex hormone estrogen interacts with the renin-angiotensin-aldosterone system, one of the most critical pathways in COVID-19 infectivity, and modulates the vasomotor homeostasis. Testosterone on the contrary enhances the levels of the two most critical molecules, angiotensin-converting enzyme 2 (ACE2) and the transmembrane protease serine-type 2 (TMPRSS2), transcriptionally and posttranslationally, thereby increasing viral load and delaying viral clearance in men as compared with women. We propose that modulating sex hormones, either by increasing estrogen or antiandrogen, may be a therapeutic option to reduce mortality from SARS-CoV-2.